Less Ads, More Data, More Tools Register for FREE

Pelatro describes solid recent trading

Fri, 23rd Jun 2023 14:47

(Sharecast News) - Customer engagement and software specialist Pelatro said in an update on Friday that it has secured several new contracts with large customers recently, further bolstering its recurring revenue base.

The AIM-traded firm, which was holding its annual general meeting, said recent contract wins underscored its continued success in attracting high-profile clients.

As a result, Pelatro now boasted a portfolio of 28 customers, representing a diverse range of industries, contributing to annual recurring revenue (ARR) of more than $7m.

The company added that it had seen strong demand for change requests from its current client base, resulting in contracted revenues of around $1.7m already this year.

"Our pipeline remains strong at around $23m, including some $5m of non-telco prospects - its highest ever level and which we are confident will produce results in the coming months and years," said non-executive chairman Harry Berry.

At 1423 BST, shares in Pelatro were up 3.83% at 8.05p.

Reporting by Josh White for Sharecast.com.


Shares in this article

Related News

AIM WINNERS & LOSERS: Getech shares drop as interim loss widens
25 Sep 2023

AIM WINNERS & LOSERS: Getech shares drop as interim loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Crimson Tide + 2 more shares
Pelatro lowers 2023 revenue forecast but pipeline remains strong
25 Sep 2023

Pelatro lowers 2023 revenue forecast but pipeline remains strong

(Alliance News) - Pelatro PLC on Monday lowered its full-year revenue expectations after experiencing delays.

TRADING UPDATES: Braemar investigation to end; Marula reports delay
22 Sep 2023

TRADING UPDATES: Braemar investigation to end; Marula reports delay

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday, Thursday and Wednesday and not separately repor...

Allergy Thera. + 2 more shares